0.8047
price up icon0.71%   0.0057
after-market Dopo l'orario di chiusura: .82 0.0153 +1.90%
loading

Immunic Inc Azioni (IMUX) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- - - -
Operating Expenses
0.96%
27.08
26.82 25.63 25.73 22.81
Provision For Loan, Lease, And Other Losses
3.77%
0.055
0.053 - - -
Depreciation and Amortization
0.00%
0.043
0.043 - - -
Operating Income/Loss
0.96%
-27.08
-26.82 -25.63 -25.73 -22.81
Nonoperating Income/Loss
80.55%
0.263
1.352 0.456 1.358 1.434
Income/Loss From Continuing Operations Before Tax
5.29%
-26.82
-25.47 -25.18 -24.37 -21.38
Income/Loss From Continuing Operations After Tax
5.29%
-26.82
-25.47 -25.18 -24.37 -21.38
Net Income/Loss
5.29%
-26.82
-25.47 -25.18 -24.37 -21.38
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
30.42%
132.18
101.34 0.1765 101.27 101.27
Diluted Average Shares
30.42%
132.18
101.34 0.1765 101.27 101.27
Basic Earnings Per Share
20.00%
-0.20
-0.25 -0.25 -0.24 -0.21
Diluted Earnings Per Share
20.00%
-0.20
-0.25 -0.25 -0.24 -0.21
Common Stock Dividends
-
- - - -
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$86.96
price up icon 1.14%
$27.08
price up icon 4.60%
$23.52
price down icon 1.34%
$100.42
price down icon 0.20%
$143.50
price down icon 1.24%
biotechnology ONC
$336.26
price up icon 1.27%
Capitalizzazione:     |  Volume (24 ore):